Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ranliang Cui"'
Publikováno v:
Annals of Medicine, Vol 55, Iss 1, Pp 820-836 (2023)
AbstractObjective The exploration of non-invasive biomarkers for assessing tumor response is critical to optimize treatment decisions. In this study, we aimed at determining the potential role of RAI14 in the early diagnosis and evaluation of chemoth
Externí odkaz:
https://doaj.org/article/c1f6335c55c2464ca1bbcbfd7d206139
Autor:
Ranliang Cui, Chaomin Wang, Tiantian Li, Jialei Hua, Ting Zhao, Li Ren, Yichao Wang, Yueguo Li
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background The incidence and mortality of invasive breast cancer (IBC) are increasing annually. Hence, it is urgently needed to determine reliable biomarkers for not only monitoring curative effects, but evaluating prognosis. In present stud
Externí odkaz:
https://doaj.org/article/9800e85c18434993a8e4be500f7a15ad
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: The purpose of current research is to explore the function of retinoic acid-induced protein 14 (RAI14), being a reciprocal protein of carboxypeptidase N1 (CPN1), and as a biomarker for prognosis and immunoregulatory effects in breast cance
Externí odkaz:
https://doaj.org/article/eb0362766f1345da8994e56f5cf6135c
Autor:
Tiantian Li, Yueguo Li, Ranliang Cui, Li Ren, Jialei Hua, Ting Zhao, Chaomin Wang, Yichao Wang
Publikováno v:
Cancer Cell International
Cancer Cell International, Vol 21, Iss 1, Pp 1-12 (2021)
Cancer Cell International, Vol 21, Iss 1, Pp 1-12 (2021)
Background The incidence and mortality of invasive breast cancer (IBC) are increasing annually. Hence, it is urgently needed to determine reliable biomarkers for not only monitoring curative effects, but evaluating prognosis. In present study, we aim
Publikováno v:
Cancer Management and Research. 11:2545-2551
Objectives The role of retrospective analysis has evolved greatly in cancer research. We undertook this network meta-analysis to evaluate retrospectively the diagnostic value of ROMA in ovarian cancer. Materials and methods We systematically retrieve
Autor:
Ranliang Cui, Chaomin Wang, Xi Wei, Jin Zhang, Luchen Chang, Ying Li, Ting Zhao, Yueguo Li, Linfei Hu
Publikováno v:
Anti-cancer agents in medicinal chemistry. 21(16)
Background: Hepatitis B virus X protein (HBx) is an indispensable progression factor in Hepatocellular Carcinoma (HCC). CCL15 could be a peculiar proteomic biomarker of HCC with tumorigenesis and tumor invasion. Objective: The aim of study was to exp
Publikováno v:
Anti-cancer agents in medicinal chemistry. 20(17)
Background: The incidence and mortality of breast cancer are increasing annually. Breast cancer seriously threatens women's health and quality of life. We aimed to measure the clinical value of CPN1, a new serum marker of breast cancer and to evaluat
Publikováno v:
Laboratory medicine. 51(4)
Objective To explore novel biomarkers for patients with pancreatic ductal adenocarcinoma (PDAC), from the perspective of tumor hypoxia. Methods We screened 29 differentially expressed and hypoxia-upregulated genes from the Oncomine database. A total
Publikováno v:
Anti-cancer agents in medicinal chemistry. 16(9)
Background: Carboxypeptidase N (CPN) is highly expressed in breast cancer and plays an important role in cleaving specific polypeptide fragments within the tumor microenvironment, so here we studied the important role of its invasion and migration in
Autor:
Cui, Ranliang1 (AUTHOR), Wang, Chaomin1 (AUTHOR), Li, Tiantian2 (AUTHOR), Hua, Jialei1 (AUTHOR), Zhao, Ting1 (AUTHOR), Ren, Li1 (AUTHOR) liren@tmu.edu.cn, Wang, Yichao3 (AUTHOR) wangyichaobei@126.com, Li, Yueguo1 (AUTHOR) yli08@tmu.edu.cn
Publikováno v:
Cancer Cell International. 10/28/2021, Vol. 21 Issue 1, p1-12. 12p.